Literature DB >> 30724979

[Epithelial tumors of salivary glands. Review of 286 pathology reports].

Andrés Campolo González1, Hernán Ramírez Skinner1, Alex Vargas Díaz1, Augusto León Ramírez1, Ignacio Goñi Espildora1, Antonieta Solar González2.   

Abstract

BACKGROUND: Epithelial tumors of the salivary glands, including benign tumors and aggressive malignancies with different prognoses, are uncommon. AIM: To describe the frequency and distribution of salivary gland tumors according to age, gender and anatomical location.
MATERIAL AND METHODS: Review of pathological reports of salivary gland tumors of a Pathology laboratory at a clinical hospital from 2006 to 2016.
RESULTS: Five hundred ninety salivary gland biopsies were reviewed. Of these, 286 (49%) were primary epithelial tumors of the salivary glands. Two hundred thirty (80%) were benign and 56 (20%) were malignant tumors. Regarding location, 274 (96%) were in the major salivary glands, and 12 (4%) in the minor salivary glands. The most common histological types were pleomorphic adenoma for benign tumors in 172 cases, followed by papillary cystadenoma lymphomatosum in 33 cases. Mucoepidermoid carcinoma was the most common malignant tumor in 14 cases.
CONCLUSIONS: These results are similar to reports from abroad, however more studies are necessary to be able to establish a more representative and updated analysis.

Entities:  

Mesh:

Year:  2018        PMID: 30724979     DOI: 10.4067/S0034-98872018001001159

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  2 in total

1.  Intra-Cystic (In Situ) Mucoepidermoid Carcinoma: A Clinico-Pathological Study of 14 Cases.

Authors:  Saverio Capodiferro; Giuseppe Ingravallo; Luisa Limongelli; Mauro Giuseppe Mastropasqua; Angela Tempesta; Gianfranco Favia; Eugenio Maiorano
Journal:  J Clin Med       Date:  2020-04-18       Impact factor: 4.241

2.  Cell adhesion molecules' altered profile in benign and malignant salivary gland tumors. The paradigm of beta4-integrin, desmoglein-2, ICAM-1 and CD44s.

Authors:  Dimitrios Andreadis; Athanasios Poulopoulos; Apostolos Epivatianos; Alexandros Nomikos; Dimitrios Parlitsis; Konstantinos Christidis; Calypso Barbatis; Dimitrios Kavvadas; Alexandros Toskas; Theodora Papamitsou; Dimitrios Antoniades
Journal:  J Biol Res (Thessalon)       Date:  2020-12-07       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.